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, and there is a dedicated system of intracellular lipid traffic to achieve this lipid compositional heterogeneity. There are also lipid transfer systems outside cells for such basic functions as scavenging lipids from the environment.
Traffic of membrane vesicles in the secretory pathway of eukaryotic cells is invariably coupled to moving lipids. However, lipids must also be supplied to compartments that do not receive vesicular traffic, thus requiring an alternative non-vesicular lipid transport 2 . Even for organelles in the secretory pathway, lipids are extensively trafficked by non-vesicular means. This non-vesicular transport might have multiple purposes, including maintenance of a membrane composition that cannot be achieved by vesicles (for example, delivering lipids with very few membrane proteins, as found in phagophore membranes during autophagy) 3 . Non-vesicular traffic also allows rapid alterations of lipidome, for example, supporting the adjustment of the plasma membrane to environmental changes 4 . Mammalian cells must also correct any adverse lipid movement between donor and acceptor compartments caused by vesicular traffic. These situ ations call for changes in membrane lipids without changes in membrane proteins. There are two main lines of experimental evidence for non-vesicular lipid traffic between compartments that are efficiently linked by vesicular traffic 5 . The first is the speed of transport: phospholipids and cholesterol move bidirectionally between the endoplasmic reticulum (ER) and the plasma membrane much more quickly (t ½ = 2-5 min) than vesicular traffic would allow [6] [7] [8] . Second, chemical or genetic disruption of the secretory pathway has little effect on bulk cellular lipid transport between the ER and plasma membrane 7, [9] [10] [11] . The hydrophobicity of lipids that allows them to form hydrophobic barriers also prevents their movement across the cytoplasm or between cells. Such movement is entropically unfavourable owing to the high activation energy required for the initial step of lipid desorption 12, 13 . The so-called lipid transfer proteins (LTPs) were postulated to facilitate transfer of lipid components of bilayers
Phagophore
The double membrane, also termed isolation membrane, that serves as the initiation site for autophagy. Various ATG proteins are recruited to the phagophore to create the autophagosome.
across the aqueous phase by decreasing this activation energy 14 . LTPs have since been studied in vitro as enhancers of lipid movement between liposomes. To date, hundreds of LTPs have been found, with members in all species, from bacteria to animals. The one feature that unites LTPs is that they provide hydrophobic environments where lipids are at much lower free energy levels than if they were left free in aqueous solution. Most LTPs have been found to form a cavity, resembling a box, with a hydrophobic lining, allowing the lipid to fit inside 15, 16 ( FiG. 1a) . Stoichiometry is typically one LTP to one lipid, which is selected both for its head group and for its acyl chain length. This selectivity implies a specific interaction of lipid with distinct residues within the cavity. Several LTPs are bispecific, meaning they can bind two lipids with different head groups. LTPs with cavities move lipids one at a time from the donor to acceptor compartment, either returning empty to achieve net lipid traffic or, as is the case for many bispecific LTPs, returning with a different lipid to achieve lipid exchange.
This Review builds on previous surveys of LTPs 17 to include considerable recent advances in our understanding of how proteins mediate the transfer of the lipid components of membranes. Our discussion is restricted to the transport of hydrophobic molecules that are large enough to contribute to membrane structuremembrane lipids or their adducts. By this definition, we have excluded proteins such as fatty acid binding proteins and lipocalins that bind and transfer other, smaller, hydrophobic molecules such as fatty acids and hydrophobic vitamins. One area of progress we highlight is that many LTPs are localized to sites where two organelles come close together to form a narrow gap (typically ≤30 nm) that can be bridged by the LTP itself. These sites of contact between different organelles, known as membrane contact sites, enable the anchoring points of the LTP to be static, while the domain with the lipid binding cavity transfers lipid cargo between the two organelles. An exciting development is also the discovery of LTPs that, as opposed to being box-like transporters, form open bridges or closed tubes that cross between membranes, allowing the lipid to move in the absence of protein movement. We also discuss several ideas about how LTPs impose direction on lipid traffic, and we address the ways in which LTP malfunction can contribute to disease. (2), donor membrane undocking (3), diffusion (4), acceptor membrane docking (5) , lipid deposition (6), acceptor membrane undocking (7) and further diffusion (8) . c | Conformation of StAR-related lipid transfer protein 4 (STARD4). Top: cross sections of the crystal structure of STARD4 (PDB: 1JSS). Middle: cartoon illustrating the hydrophobic cavity lining and the hydrophobic face of the carboxy-terminal α-helix (both in green). Bottom: cartoon depicting conformational changes associated with lipid loading. In the open, membrane-binding conformation of STARD4, the carboxy-terminal α-helix rotates, exposing its hydrophobic face to the membrane, and the omega-1 (Ω1) loop bends away from the cavity , creating the opening for the lipid.
Structures and conformation
At the structural level, 27 protein families form hydrophobic cavities that transfer membrane bilayer lipids (TAble 1) . LTPs in the same family can bind different ligands, even if they share considerable sequence homology 18 . In this section, we briefly describe how LTPs solve the problem of moving hydrophobic lipids through hydrophilic environments.
Box-like lipid shuttles
The archetypal form of LTP resembles a box, with an internal cavity large enough for one lipid molecule. Lipid transfer requires the LTP to shuttle between donor and acceptor compartments with several steps: membrane docking, lipid extraction, undocking, cytosolic diffusion and then the reverse steps for deposition (FiG. 1b) . Most domains that form box-like cavities also have residues that move, equivalent to a lid that opens and closes. However, some LTPs such as MlaC in bacteria have no lid, exposing the lipid head group to the aqueous environ ment 19 (FiG. 1a) . Here, we describe some examples of box-like LTPs.
StARkin superfamily. The StARkin (relatives (kin) of steroidogenic acute regulatory protein (StAR)) superfamily contains domains with similar structure to StAR, the founding member of the StAR-related transfer (StART) family. StARkins, by far the largest grouping of LTPs, have a characteristic arrangement of both α-helices and β-sheets that fold to create an internal hydrophobic cavity 20 . StAR was identified first, but the closely related STARD4 (StAR-related lipid transfer protein 4) is better understood mechanistically 21 ( FiG. 1c) . Membrane docking by STARD4 is initiated by electrostatic interactions between an electropositive surface protein patch and anionic membrane lipids. The entrance to the internal cavity, which is near the electropositive patch, is between a long amphipathic α-helix and the so-called omega-1 (Ω1) loop 22 . NMR shows that the α-helix rotates so that its hydrophobic face engages with the bilayer and the Ω1 loop opens, although it does not embed in the membrane 21 (FiG. 1c) .
The movement of these elements is essential for lipid transfer. The application of NMR to address these questions is far-reaching, because it reveals conformational changes that take place at the highly relevant, but little explored, timescale of microseconds to milliseconds during which lipid transfer occurs.
Crystal structures indicate that similar movements occur in phosphatidylinositol (PtdIns) transfer proteins (PITPs), which are bispecific StARkins, transporting PtdIns and phosphatidylcholine (PtdCho) (PITPα/ PITPβ) or PtdIns and phosphatidic acid (PA) (membraneassociated PtdIns transfer protein 1 (PITPNM1); also known as RdgBα in flies) 23, 24 . Compared with STARD4, the entrance to the cavity of PITPs is closed by a combination of a much expanded Ω1 loop called the exchange loop and an elongated extreme carboxyl terminus. When engaged with the membrane, both the exchange loop and the carboxyl terminus move into an open conformation, exposing the site for phospholipid binding 23, 25 . PITPs have other additional structural elements, including the so-called G-helix near the cavity opening, which moves and unwinds when PITPs are engaged with the membrane 25 . PITPα also illustrates a mechanism often employed by LTPs, whereby a loop of the protein inserts hydrophobic residues into the bilayer to enhance dwell time during lipid exchange 26 . The StARkin family closest to PITP are the PRELI domain-containing proteins (also known as SLMO proteins in metazoa and Ups in yeast), which are found in the intermembrane space of mitochondria. PRELI domains bind phospholipids such as PA or phosphatidylserine (PtdSer), or both [27] [28] [29] [30] . Instead of a G-helix, PRELIs have a shared obligatory small helical subunit (TP53-regulated inhibitor of apoptosis 1 (TRIAP1) in humans and Mdm35p in yeast) that binds the PRELI domain in a similar position to the G-helix in PITPs. Membrane docking by these proteins necessitates dissociation of the PRELI-TRIAP1 complex 28, 31 , indicating that large conformational changes can accompany lipid loading and unloading.
Sec14. Sec14 domains (also known as CRAL-TRIO domains) are widespread in all eukaryotes [32] [33] [34] . Yeast Sec14p is bispecific for PtdIns and PtdCho, similar to StARkin PITPs 35, 36 . Sec14 domains have an all-helical structure with no structural homology to StARkins, implying convergent evolution on a common function. The lid of the lipid binding pocket of Sec14p moves substantially (~17.5 Å) during opening and closing, which is regulated by lipid occupancy 15, 37, 38 . OSBP-related proteins. The large family of oxysterolbinding protein (OSBP)-related proteins (ORPs) are all LTPs, but not all transfer sterol as the name would suggest. They are bispecific, and their one common ligand is a phosphoinositide, usually PtdIns 4-phosphate (PtdIns(4)P) 39, 40 . ORPs can then be classified according to their specificity for the counter-ligand: OSBP and its closest homologues bind sterol; ORP5, ORP8 and their homologues bind PtdSer 41, 42 , and other ORPs (for example Osh3 in yeast) are suggested to bind other lipids 43 . As for the phosphoinositide ligand, although many ORPs are specific for PtdIns(4)P, PtdIns 4,5-bisphosphate (PtdIns(4,5)P 2 ) has also been found to be a ligand for ORP5, ORP8 (reF. 44 ) and to a minor extent for OSBP 45 . Transfer of phosphoinositides by LTPs was quite unexpected, as phosphoinositide distributions must be tightly controlled for them to act as organellar signposts 46 . Phosphoinositide transfer is also a special case because it provides a fairly simple system to impart direction ality on traffic of the second lipid (see subsection on counter-transport of lipids below) 39 .
Bridge-like LTPs
Whereas a box-like LTP has a singular access point to its binding cavity, a bridge-like LTP has an opening that extends along its length. The extended opening forms a seam that theoretically allows lipid to slide while the protein remains stationary (FiG. 2) . These LTPs have been found in multimers that make continuous elongated lipid transfer modules similar to bridges. Prokaryotic Lpt. The lipopolysaccharide (LPS) transport (Lpt) operon comprises seven genes (LptA-LptG), involved in LPS transport from the inner to the outer membrane of Gram-negative bacteria. LPS has up to six fatty acyl chains and a bulky polysaccharide head group with more than 200 sugars. The seven Lpt proteins are organized in two membrane subcomplexes: LptB 2 -LptFLptG-LptC in the inner membrane, which modulates LPS insertion and flipping to the periplasmic face, and LptDLptE in the outer membrane, which inserts LPS into its outer leaflet. In between the membrane sub complexes sits LptA. LptA folds into a U-shaped structure, the inside surface of which is hydrophobic to protect the lipid tails of LPS, while the head groups are exposed 47 (FiG. 2Aa) .
Domains in LptC and LptD have the same U-shape 48, 49 , and an in-line complex of LptC-LptA (n) -LptD (where n signifies multiple sub units) forms a bridge that spans the entire periplasmic gap (~21 nm) between the subcomplexes in the inner and outer membranes (FiG. 2Ab,c) . This arrangement creates a path for LPS from the start (inner membrane) to the end (outer membrane) of its route.
Tubular lipid binding proteins. Given the presence of a bridge-like LTP complex in prokaryotes, it is appealing to look for eukaryotic counterparts. Tubular lipid binding domains (TULIPs) have repeatedly been suggested to adopt a multimeric bridge-like form. However, for both extracellular and intracellular TULIPs, strong evidence for their function as bridges is lacking. Currently, a shuttle mechanism of lipid transport is more widely accepted for these LTPs.
TULIPs are elongated cones with extended openings along their length that in some cases resemble seams 50 ( FiG. 2ba) . Similar to LptA, hydrophobic portions of lipids are protected within a groove-shaped cavity, and hydrophilic head groups are exposed. Cholesteryl ester transfer protein (CETP) is a secreted glycoprotein that is found in the plasma, where it transfers cholesterol esters from high-density lipoprotein (HDL; 'good cholesterol') to (very) low-density lipoprotein ((V)LDL; 'bad cholesterol') 51 , making it an attractive drug target (see also section on LTPs and disease below) 52 . Cholesterol esters have no hydrophilic portion; therefore, they bind solely at the base of the groove 53 . Most TULIPs form head-to-head dimers that are highly elongated, shaped like bananas, up to 13 nm long (FiG. 2bb) . Electron microscopy images of purified CETP in complex with LDL and/or VLDL suggest that the TULIP dimer can form a bridge between lipoproteins so that lipids might travel the entire length of the grooves across the dimer, analogous to LPS transfer along LptC-LptA (n) -LptD 51 . However, antibodies that bind and obstruct the ends of CETP do not inhibit its function, suggesting that CETP shuttles lipids similar to the box-like LTPs 54 rather than functioning as a bridge.
Many years after the extracellular TULIPs were discovered, they were shown to have intracellular counterparts in the synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain family [55] [56] [57] [58] . Similar to extracellular TULIPs, SMP domains mostly dime rize head-tohead 56 (FiG. 2bb) , and they form larger complexes 57 (FiG. 2bc and inset and see next paragraph). This observation suggests that SMPs form long lipid bridges as was proposed for CETP 55 . However, the evidence that the extreme ends of the SMP complexes are lipid entry and exit points is almost all indirect and based on mole cular dynamics simulations 50 . Therefore, as for CETP, the current results suggest that a complex of multiple SMP domains shuttles the lipid across contact sites (FiG. 2bd) . For extended synaptotagmin 2 (E-Syt2), which transfers a range of glycerolipids between the ER and the plasma membrane, the shuttle mode of action is more strongly supported because the dimer formed by its SMP domains is too short to bridge the gap between the membranes 56 . An SMP dimer even more likely to act as a shuttle is formed by transmembrane protein 24 (TMEM24; also known as C2CD2L), which is selective for PtdIns over other phospholipids. The crystal structure of TMEM24 shows that lipid cavities of the two monomers do not join together at the head-to-head dimer interface; therefore, lipids cannot flow along the length of the dimer 59 .
The er-mitochondrial encounter structure (ERMES) is a complex that bridges between ER and mitochondria in yeast, which contains three proteins with SMP domains: maintenance of mitochondrial morphology 1 (Mmm1), mitochondrial distribution and morpho logy 12 (Mdm12) and Mdm34 (reF.
55
). In mammals, the ancestors of which lost ERMES, a different SMP-containing protein, PDZ domain-containing protein 8 (PDZD8), has a similar localization, although its role in lipid traffic has yet to be tested 58 . The SMP domains of ERMES proteins combine into a variety of complexes -not only head-to-head homodimers as seen in CETP but also heterotetramers with an Mmm1 dimer sandwiched between Mdm12 monomers (FiG. 2bc and inset), and Mdm34 may join in to make even larger complexes 57, 60 . Individual ERMES SMPs poorly transfer lipids between liposomes, but Mdm12 and Mmm1 in combination transfer multiple phospholipids 10-100 times more quickly than either monomer 61 . This multimeric complex, which may bind as many as six phospholipids at once, has inspired two models of transport that are alternatives to LTP shuttles. The first is a static bridge with an interconnected path for lipid to move along (FiG. 2be) . However, the narrow head-to-tail connections of static SMP domains in available crystal structures do not seem to provide a hydrophobic path that would be wide enough for lipid to traverse. Second, an idea (with no evidence as yet) is that a linear multimeric SMP bridge may not necessarily be static, but that its subunits may constantly change orientation, flipping by 180° to pass the lipid between subunits across head-to-head interfaces, similar to a chain of firefighters passing buckets of water 61 (FiG. 2bf) .
Tube-like lipid conduits
It has now been shown that LTPs do not need individual hydrophobic cavities because the cavity can be formed from parts of multiple building blocks. Bacterial mammalian cell entry (MCE) domains form fully enclosed tubes with internal hydrophobic environments separate from the surrounding aqueous environment. Electron microscopy structures of MCE complexes show that these domains multimerize in two ways. First they Lipopolysaccharide (lPS). Also known as endotoxin, lPS is a component of the outer membrane of Gram-negative bacteria with structural and protective functions. it is also a strong pro-inflammatory molecule in the immune system of the host.
Gram-negative bacteria
Group of bacteria that do not stain with the crystal violet used in the Gram staining method. They have two membranes, with lipopolysaccharide confined to the outer leaflet of the outer membrane. A peptidoglycan cell wall is found in the periplasmic space between the outer and inner (cytoplasmic) membranes.
ER-mitochondrial encounter structure
(erMeS). A complex of four proteins localized to endoplasmic reticulummitochondrial contact sites. The complex arose in the common ancestor of fungi, animals and protists and has since been lost in animals.
hexamerize to form a disc with a central pore lined by hydrophobic residues. Second, discs can stack up to extend the pore into a hydrophobic tube 62 
(FiG. 2C).
MlaD, YebT and PqiB are MCE proteins in the intermembrane space of bacteria. All three proteins form polymers with six-fold radial symmetry that have been shown to contain phospholipids, although lipid transfer by these proteins is yet to be directly tested 62 . MlaD, which has one MCE domain, forms a single hexameric disc (FiG. 2Ca ) that accepts lipids from MlaC, a soluble LTP (FiG. 2Cb) . YebT has seven conserved MCE domains that each hexamerize. Together, the 42 YebT domains contribute to seven stacked rings with a hydrophobic central tube ( FiG. 2Cc and inset) . PqiB has three MCE domains and an additional carboxy-terminal α-helix. In addition to hexamerization of MCE into discs, the helix of PqiB forms a six-bundle superhelix with a central hydrophobic pore (FiG. 2Cd) , resulting in a striking syringe and needle shape (FiG. 2Ce and inset). Lipid import into plastids, which are endosymbionts descended from cyanobacteria, requires TGD2, a chloroplast MCE protein 63 , which likely forms a similar structure to PqiB, but with only one disc. Site of action LTPs were initially thought to be purely cytosolic proteins because their activity was identified in cytosolic extracts 2 . However, moving lipids between two membrane compartments requires that LTPs function at membranes 5 . Therefore, their membrane targeting is an important and regulated aspect of their activity.
Dual membrane targeting
To access lipid membranes, many LTPs contain domains or motifs that target them to not just one organelle but two (FiG. 3) . Dual targeting ensures that LTPs encounter the source and destination of their ligands. If the two targeting domains or motifs are both available for interaction, then LTPs tend to localize to sites where receptors for both these domains or motifs can be simultaneously engaged. Because many LTPs can extend up to 30 nm, LTPs with two targeting domains are therefore found where the gap between the two organelles is bridgeable by the LTP 64 (FiG. 3) . This capacity for dual targeting is a simple explanation for the large proportion of LTPs that are found at membrane contact sites 65 . Many LTPs target the ER. For SMPs, LTPs anchored at membrane contact sites (LAMs; which belong to the StARkin superfamily) and some ORPs, ER targeting is irreversible and occurs via transmembrane domains 66, 67 . An alternative, revers ible means of ER targeting used by many LTPs is binding to the ubiquitous ER integral protein VAMP-associated protein (VAP) 68 . Binding to VAP requires a short FFAT motif (two phenylalanines in an acidic tract), which is present in at least four different LTP families (FiG. 3) .
Targeting of non-ER membranes by LTPs can be achieved by interaction with proteins, lipids or both. The most common membrane-targeting domains found in LTPs are pleckstrin homology (PH)-like domains and C2 domains. For example, a PH-like domain in Lam6p (also known as Ltc1p) targets ER-mitochondrial contacts coincident with ERMES 67 , possibly binding one of its subunits or an associated factor 69 . OSBP, ceramide transport protein (CERT; also known as COL4A3BP) and four-phosphate adaptor protein 2 (FAPP2; also known as PLEKHA8) are three LTPs with highly homologous PH domains, which bind a combination of phosphoinositide lipids (PtdIns(4)P and PtdIns(4,5)P 2 ) and ARF1 GTPase, two factors that coincide only at the trans-Golgi network (TGN). For CERT, the PH domain and its FFAT motif localize it to ER-TGN contacts, where it transfers ceramide out of the ER.
LTP targeting can be regulated by post-translational modification. CERT targeting is affected by two different phosphorylation events, one of which activates the FFAT, whereas the other causes autoinhibitory binding of the PH and StARkin domains [70] [71] [72] . LTPs and their localization can also be regulated by Ca 2+ signalling as shown for E-Syt1. E-Syts have three or five C2 domains. E-Syts are held in the ER because of a hydrophobic segment that forms a hairpin anchor 73 , and E-Syt1 is activated by relocalization to parts of the ER contacting the plasma membrane, where its fifth C2 domain (C2E) binds PtdIns(4,5)P 2 . Unlike E-Syt2 and E-Syt3, which have C2 domains that constitutively bind PtdIns(4,5)P 2 , C2E in E-Syt1 requires high Ca 2+ to bind PtdIns(4,5)P 2 . Thus, E-Syt1 localizes near to the plasma membrane only in the event of cell stimulation resulting in Ca 2+ influx. The rise in cytosolic Ca 2+ breaks two autoinhibitory interactions in E-Syt1 -between C2C and C2E and between C2A and SMP -so that after stimulation the C2E is finally free to bind PtdIns(4,5)P 2 and the SMP domain is available for phospholipid transfer 74 . The SMP domain of E-Syt1 can also bind diacylglycerol (DAG), which is generated from PtdIns(4,5)P 2 by phospholipase C upon cell stimulation. Thus, stimulation-dependent recruitment of E-Syt1 to ER-plasma membrane contacts allows trafficking of DAG from the plasma membrane to ER for re-synthesis of PtdIns(4,5)P 2 (reF.
75
).
LTPs without membrane-targeting domains
Some LTPs that have no targeting domain or motif detected by bioinformatics still exhibit specific membrane targeting (for example, short OSBP homologues) 41, 76 . Furthermore, LTPs that are diffuse in the cytosol (for example, STARD4) must still target membranes to acquire lipids, although the interaction is transient and can be difficult to detect 77 . For these LTPs, interactions with membrane proteins or lipids are likely to be low affinity, possibly too low to readily measure, in contrast to the much higher affinity interactions that produce tight membrane attachment. showing its U-shaped cross section, which makes a seam along which lipid can slide. Ab | LptA forms end-to-end multimers with similarly folded domains in LptC and LptD. Note that the bridge is helical, twisting about its main axis, but the twist has been omitted in the diagram. Ac | This bridge is preceded by a pump (equivalent to LptB; see also FiG. 4a) pushing lipid molecules into one end of the bridge. B | Three models for lipid transfer by tubular lipid binding domains (TULIPs) in the endoplasmic reticulum-mitochondrial encounter structure (ERMES) complex. Ba | Similar to other TULIPs, the synaptotagminlike mitochondrial-lipid-binding protein (SMP) domains of Mmm1, Mdm12 and Mdm34 are cone-shaped lipid transfer proteins (LTPs), possibly with seams running along one side. Structure on the right is of another TULIP domain, extended synaptotagmin 2 (E-Syt2; PDB: 4P42), cut away to reveal two bound phospholipids and a potential tunnel that might form between head-to-head dimers. Bb | Like most TULIPs, all three ERMES SMPs form head-to-head dimers. Bc | The Mmm1 dimer can be capped by Mdm12 subunits to make heterotetramers. Inset shows a class average of cryo-electron microscopy images of Mdm12-Mmm1 heterotetramers. Bd-Bf | Lipid traffic by ERMES might occur by three routes: shuttling, in which different cavities in the complex (here shown as a dimer) pick up lipids and shuttle them between membranes (part Bd); bridging by a lipid slide, with one continuous seam across three subunit interfaces, one of which is head-to-head and two head-to-tail (part Be); bridging by a multimeric lipid shuttle (here illustrated as a Mmm1-Mdm12-Mdm34 trimer), in which lipid crosses only head-to-head interfaces and net movement is facilitated by rotations of the subunits (part Bf). C | Different LTP tubes constructed by mammalian cell entry (MCE) multimers. Ca | MCE domains (without individual hydrophobic cavities) form discs of six subunits surrounding a hydrophobic central pore. The crystal structure is that of MlaC (PDB: 5UW2). Cb | A single MlaD disc acts as a docking site for the shuttle LTP MlaC for lipid transfer from the bacterial outer membrane into the inner membrane. Cc | YebT has seven MCE domains that form a stack of seven discs, with 42 MCE domains in total. Inset shows a class average cryo-electron microscopy image of YebT. Cd | In addition to containing three MCE domains, PqiB has a carboxy-terminal α-helical extension. After hexamerization, this extension forms a six-bundle supercoil (here shown as straight for simplicity). The supercoil forms a tube with a central cavity that matches the pore size of the preceding hexameric MCE disc. Ce | Each of the three MCE domains in PqiB forms a hexameric ring that, together with the supercoiled tube, forms a syringe-and-needle-like arrangement. The inset shows a class average of cryo-electron microphotographs of PqiB. Part Bc reprinted with permission from reF. 84, 85 .
Forcing direction of lipid transfer
Cells synthesize most of their lipids in one major site. In eukaryotes, this is the ER; for Gram-negative bacteria, lipid synthesis occurs in the inner membrane. Many lipids need to be transported up concentration gradients to achieve higher concentrations in their destination compartments. Transport up the concentration gradient consumes energy. Because LTP domains have no clear way to consume energy, they must be linked indirectly to energy-consuming cellular processes.
ATP pumps driving lipid transport
One way of moving lipid up a gradient is linking an LTP to a lipid pump that forces transfer (FiG. 4a) . A clear example of this is found in LPS traffic by the Lpt system in bacteria such as Escherichia coli (FiG. 2Ac) . The inner membrane subcomplexes contain LptB, which is an ATP-binding cassette (AbC) transporter. Members of this family use ATP to pump substrates across a membrane, here the substrate being LPS. This pumping then pushes a continuous line of LPS molecules along the rest of the Lpt pathway, which consists of LptF-LptG (for extraction from the inner bilayer), LptC-LptA (n) -LptD (bridge-like Lpt; see FiG. 2A ) and LptD-LptE (for insertion into the outer membrane) 86, 87 . Memorably, LptB filling the pathway from the bottom has been described as a 'PEZ model' , calling to mind the mechanism in the sweet dispensers that have been in circulation for more than 60 years 88 . LptB is not the only lipid pump involved in lipid export. Human ABCA1 and ABCG1 are phospholipid pumps in the same protein family as LptB. They transport phospholipids and cholesterol and induce asymmetry in the bilayer, with excess lipids accumulating in the extracellular leaflet 89 . This mechanism is used for the formation of nascent HDL particles, which are lipid bilayer nanodiscs 8-11 nm in diameter. During HDL formation, ABCA1 lipid pumping generates an activated lipid domain (a lipid reservoir), to which apolipoprotein A1 (ApoA1) is recruited. Amphipathic helices of ApoA1 take up the phospholipids and cholesterol from the activated domain to form a bilayer within the discoidal nascent HDL. Further cholesterol loading into the growing core as the disc converts into a sphere is supported by the activity of ABCG1 (reF. 89 ). In this context, ApoA1 acts as a nonspecific LTP, whereby it binds to the donor membrane, extracts the lipids and then transports them in the bloodstream as HDL particles.
Gradients created by lipid consumption
Once transferred from the donor to acceptor compartment, a lipid can be made unavailable for return, for example, by enzymatic conversion in the acceptor compartment (FiG. 4b) . A good example is provided by CERT-mediated transport of ceramide between the ER and TGN, where ceramide is subsequently converted into sphingomyelin 90 . In another example, the PA and PtdSer that are delivered from the ER to the outer mitochondrial membrane are subsequently supplied to enzymes of the inner mitochondrial membrane to make cardiolipin and phosphatidylethanolamine (PtdEtn), respectively; this transfer between mitochondrial membranes is mediated by specific PRELI domain proteins, which reside in the intermembrane space and transport either PA or PtdSer 30, 31 . The enzymes that make sphingomyelin, PtdEtn and cardiolipin are 'exceptions to the rule' of the confinement of lipid biosynthetic enzymes to the ER. These specific, local biosynthetic mechanisms evolved possibly because the lipids they generate have unique biophysical properties, and one hypothesis is that it could be disadvantageous to produce them in a location other than their target membrane. Of note, PtdEtn synthesis holds a unique place in lipid cell biology and exemplifies the complexity of lipid biosynthesis and transport mechanisms (see Supplementary Box 1) 91 .
Role of membrane effects
Not all the lipids in a bilayer are available for interactions with other cellular components, including with LTPs. This inaccessibility is particularly evident for cholesterol. Despite high levels of cholesterol in the plasma membrane (30-40%, compared with 5% in the ER), only a small proportion of plasma membrane cholesterol is free to interact with proteins outside the membrane 92 . In plasma membranes, there is a 'J-shaped curve' of sterol accessibility. Until a threshold concentration of chol esterol (~25%) is reached, the cholesterol is virtually inaccessible for protein interactions; for example, it is not detected by sterol-binding proteins 92 . Above this threshold, all additional cholesterol is accessible. By comparison, in an ER-like bilayer, the threshold for accessibility is less than 5% 93 . These different thresholds arise from the reversible low-affinity interactions of cholesterol with other lipids. Cholesterol binds saturated lipids, including sphingomyelin and PtdCho most strongly, and these lipids are enriched in the plasma membrane 40 . Localization of these interacting partners is thought to drive the intracellular redistribution of cholesterol via LTPs 11 (FiG. 4c) .
Thus, biological membranes have set points for sterol release that depend on which other lipids are present. Pools of sterol can be made accessible by removing 
ATP-binding cassette (ABC) transporter
A membrane-embedded protein containing an AAA ATPase domain (see below), where consumption of ATP is linked to pumping of a small molecule across the membrane. in AbCA1 and AbCG1, the pumped substrate is a phospholipid, the movement of which leads to cholesterol flux. the cholesterol-sequestering, saturated lipids 92 ; conversely, sterol can be shielded by increasing saturated lipid concentrations 94 . Packing defects are another property of a bilayer that can influence lipid accessibility -in this case by increasing the ability of LTPs to penetrate into the membrane. Packing defects occur when lipids have unsaturated acyl chains or where there is higher curvature (both of which are features of ER tubules), resulting in the exposure of hydrophobic regions of the bilayer to the aqueous environment 95 . These defects reduce the energy barrier to lipid either leaving or entering the bilayer (FiG. 1b,  steps 2 and 6 ).
Counter-transport of a second lipid
In 2011, a new concept was introduced for forcing the direction of lipid traffic -lipid counter-transport 39 . The concept applies to bispecific LTPs that transport two ligands, lipid A and lipid B, in different directions. A counter-current to move lipid B can develop if there is a mechanism for maintaining a strong gradient of lipid A. An LTP interacting with the membrane where lipid A levels are maintained at a high concentration will load with it. When LTP-lipid A reaches the other compartment, where lipid A levels are kept very low, it unloads lipid A and will be unlikely to reload with it. Instead, the LTP will swap to its other ligand, lipid B. LTP-lipid B can return to the starting membrane. Here, lipid A is high, therefore after lipid B release, reloading with lipid B is unlikely and as before lipid A will load 39 . Thus, a permanent gradient of lipid A forces lipid B in the opposite direction (FiG. 4d) . This mechanism of transport has been described as counter-transport similar to antiporter ion transport. However, the 'antiport' mechanism of LTPs is imperfect and is not essential for the lipid transfer as such, because transport of lipid B can still be obtained without lipid A, although the rate of this process will depend solely on the strength of the gradient for lipid B.
The counter-transport concept was first applied to ORPs where lipid A is PtdIns(4)P. This phosphoinositide is synthesized from PtdIns by multiple PtdIns 4-kinases (PI4Ks) located in different compartments of the late secretory pathway 96 , and PtdIns(4)P is hydrolysed back to PtdIns by the PtdIns 4-phosphatase SAC1 (also known as SACM1L), which is anchored in the ER 39, [97] [98] [99] . Both the PtdIns(4)P kinase and phosphatase are essential for efficient counter-transport of lipid B out of the ER, and the speed of the counter-transport is determined by the rates of PtdIns(4)P generation and degradation. Here the gradient of lipid A is created by lipid consumption (see above). Specificity for lipid B varies between ORPs, and phosphoino sitides other than PtdIns(4)P (lipid A) might also drive counter-transport 44, 45 . There is strong evidence that this counter-transport system is a powerful way to move lipids because it is hijacked by viruses to drive cholesterol into virally determined membranes in order to support viral replication (see section on LTPs and disease below) 100 . Other examples of counter-transporting LTPs are PITPNM1 (exchanging PA for PtdIns between the ER and plasma membrane) 24,101 and the PRELI protein Ups2p (exchanging PtdSer for PA between the mitochondrial membranes) 102 . ORPs that transfer lipids by counter-transport have not only a hydrophobic cavity to internalize PtdIns(4)P but also PH domains that bind the head group of PtdIns(4)P to recruit it to the contact site where lipid transfer can take place. This homeostatically adjusts membrane recruitment of the ORPs to co-vary with levels of PtdIns (4)P 97 . When the cavity of an ORP is filled by a pharmacological inhibitor, it loses the ability to traffic PtdIns(4)P, leading to accumulation of both PtdIns(4)P and ORP at the site of lipid synthesis. This finding explains the long-standing observation that OSBP translocates to the TGN when 25-hydroxycholesterol is added to cells 103 : this sol uble oxysterol fills OSBP's cavity, preventing transfer of PtdIns(4)P, which accumulates on the TGN and recruits the PH domain more tightly 96 . Because OSBP spans between the TGN and the ER via its PH domain and FFAT motif, the unnatural addition of 25-hydroxy cholesterol causes tight cross-bridging of the two compartments. In this way, inhibiting OSBP and its homologues might cause patho logy through holding membranes together too tightly 104 .
One of the lipids bound by ORPs is cholesterol. However, it is not yet known how important countertransport by ORPs is for traffic of cholesterol from the ER to the plasma membrane. In both human cells and in yeast, the overall capacity for non-vesicular traffic of sterol outstrips the amount of traffic needed for cell growth by threefold to tenfold 105, 106 . In yeast cells lacking the entire ORP family, some aspects of sterol traffic are largely unaffected, but the plasma membrane has a changed structure that radically alters the accessibility of sterol (see subsection on the role of membrane effects) 107 . This observation makes it hard to determine the extent to which ORPs directly maintain the sterol pool in the plasma membrane. One possibility is that counter-current by ORPs drives cholesterol from the ER to other locations, such as the TGN 96 or postGolgi vesicles 108 . This counter-current would allow sterol to reach and possibly exceed its local set points in these membranes.
LTP-imposed direction of traffic
The direction of lipid traffic can be driven by intrinsic properties of the LTP itself. The most obvious means of regulation is provided by the lipid cargo, which, when bound inside the cavity, may impart conformational changes that affect the external surface of the LTP and hence its transport properties. A clear example of this is Osh4p, a yeast ORP, which offloads PtdIns(4)P into ER-like acceptors much more quickly than it offloads sterol into the same liposomes 98 . This specificity correlates with the behaviour of the lid of Osh4, which is predicted to be more mobile in the Osh4-PtdIns(4)P complex than in the Osh4-sterol complex 98 . The predictions of how the lid of Osh4p behaves were obtained through computer simulations, which provide a way forwards in studies of LTPs when suitable biophysical approaches are not available (bOx 1). Once experimental techniques to study LTP dynamics on a molecular level are developed, a subsequent challenge will be to combine in vitro experiments with in vivo studies to gain a more complete understanding of LTPs in action 109 . Other effects on the LTP come from the membrane it interacts with. For example, in a simplified cell-free system Osh4 is almost incapable of unloading lipid (both PtdIns(4)P and sterol) into liposomes devoid of sterol 98 . This finding indicates that the unloading step, which has been modelled to involve a large release of free energy 110 , is highly regulated and needs to be understood in more detail 13 . A preference for particular membrane characteristics, varying from biophysical parameters such as lipid packing to the presence of specific lipid species, could help many LTPs to convert the energetics of membrane differences into lipid gradients (FiG. 4e) .
LTP function is affected not only by the lipid environment but also by protein partners that may be asymmetrically distributed between donor and acceptor membranes. It was observed that a yeast OSBP homologue interacts with Afg2p, an AAA-ATPase chaperone, which might act to dissociate it from the membrane 111 . If this type of interaction is distributed asymmetrically between donor and acceptor compartments, it might impose a direction on lipid traffic.
Box 1 | Computer simulations of lipid transport
All lipid transfer proteins (lTPs) have hydrophobic cavities that stabilize lipid after its desorption from a membrane. However, the way lTPs engage with membranes to stimulate lipid desorption, reducing the energy barrier for lipids to leave bilayers, is poorly understood. This particularly applies to identifying flexible lTP conformations that may modify the energy landscapes associated with lipid loading and unloading. These intermediate conformations are difficult to capture, and the timescale of conformational change is unknown. The fastest lipid transfer observed in living cells is about ten lipids transferred per second per LTP, corresponding to ten loading and ten unloading events per second. Before obtaining detailed information on loading and unloading events in real time, an alternative option is to model how lTPs are likely to interact with membranes by molecular dynamics computer simulations based on static crystallographic structures. Phosphatidylinositol transfer protein α (PITPα) has the same fold as steroidogenic acute regulatory protein (StAR; see StARkin superfamily section). Its lipid cargo (phosphatidylcholine or phosphatidylinositol in this case) must move ~3 nm for loading and/or unloading. molecular dynamics simulations show that the exchange loop of PITPα, which acts as a lid, moves upon bilayer insertion 101 . Taking molecular dynamics simulations to the current limit (microsecond range) is currently insufficient to capture lipid loading. The biggest movement of a lipid molecule visualized was to a distance of approximately 1 nm into the PITPα, which occurred once per microsecond. This work required 5 × 10 9 integrations (2 fs per each time frame) of an atomic model of an lTP-bilayer interface, which is at the current limit for computing power. Notably, the lipid transfer events occur over a time frame of up to 50,000 µs (reF.
132
). Thus, we have a long way to go before we will understand how lTPs engage and release the lipids they transfer.
Roles of LTPs beyond lipid traffic
The term LTP applies both to a physiological activity found in living organisms and to a laboratory definition tested by in vitro experiments with liposomes. Although scientists are interested in finding the former, the latter is much easier to measure. An important question regarding characterization of LTPs and their physiological roles is whether the presence of a domain capable of lipid transfer in vitro means that the primary role of the protein in vivo is lipid transport. In this section, we look at some of the alternative functions for LTPs.
Lipid sensing by LTPs
Many domains first identified in LTPs are found in large proteins that contain other active domains. Examples are common for Sec14-like domains, which appear with enzymatically active domains, including RhoGEF, tyrosine phosphatase and RasGAP domains in triple functional domain protein (TRIO), tyrosine-protein phosphatase non-receptor type 9 (PTPN9) and neurofibromin 1, respectively. StARkin domains co-occur with RhoGAP domains in DLC proteins (for 'deleted in liver cancer') and in some acyl-CoA thioesterases. In plants, StARkin domains are often found together with transcription factor domains in proteins that have lipid-regulated transcription similar to nuclear steroid receptors 18 . Thus, box-like LTP domains might function to signal lipid occupancy by changing the external structure of the protein after lipid binding.
One proposed lipid sensor is OSBP, which has been shown to interact with two phosphatases, but only when occupied by sterol 112 , although more studies are needed to validate this mechanism. Another proposed sensor is ORP1L, which through conformational changes was suggested to signal cholesterol levels on endosomes to regulate the formation of ER-endosome contact sites and the recruitment of endosome-positioning machineries 113 . However, more recent work suggests that the effects of ORP1L on endosome positioning can be explained purely through it bridging endosomes to the ER and transferring cholesterol between the two membranes 114 . Overall, the few clearcut examples of LTPs as sensors come from studies of large multidomain proteins. Before ascribing a lipid-sensing role to an LTP, it is important to first study the role of lipid traffic by this LTP and its functional consequences for the process under investigation. One way to do this is to test whether a different protein with equivalent lipid transfer activity can replace its function 77 .
LTPs presenting lipid to other proteins
There are several situations in which lipids are passed from one protein to another for which lipid presentation might be a better description than transfer or traffic. Presentation of LPS by LBP to CD14, then to MD2 and TLR4 in the non-adaptive immune system, has already been described (see discussion of extracellular LTPs above). For adaptive immunity to lipids, γδ T cells recognize pathogen-derived lipids, which are presented by CD1, a major histocompatibility complex (MHC) class-I-like surface molecule on antigen-presenting cells. Unlike the peptide binding groove of MHC class I, the groove of CD1 isoforms is hydrophobic and binds lipids. Loading of CD1 with lipids takes place in endosomes and lysosomes, with saposins and other soluble LTPs in the late endosome and/or lysosomal lumen presenting the lipid to CD1 (reF.
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). Another LTP, microsomal triglyceride transfer protein large subunit (MTTP), has a parallel role in regulating lipid presentation by CD1 -in the ER, MTTP allows CD1 to exit the ER, presumably loading it with endogenous lipid to allow its correct folding, thereby avoiding ER-associated degradation 116 . Saposins, along with another endolysosomal protein, monosialic ganglioside 2 (GM2) activator protein (GM2AP), are also 'activator proteins' for enzymes that break down glycosphingolipids. Here, 'activator protein' means that saposin and GM2AP stimulate these enzymes, which have very low activities (at least measured in vitro in studies with liposomes), by presenting the lipid substrates to them 117 .
LTPs as lipid modifiers
LTPs have cavities that engulf the hydrophobic part or the entire lipid molecule, providing the opportunity for labile bonds in the lipid to be remodelled or new groups to be added, thereby generating new lipids. One example is GM2AP, which, in addition to activating (presenting) glycolipids such as GM2, has been shown to hydrolyse PtdCho with the generation of lyso-PtdCho and oleic acid Cholesterol transfer and disease Altered function of human LTPs is linked to many diseases, too many to comprehensively address here. Instead, we will consider in detail transport of cholesterol to illustrate LTP-related pathology. This major lipid species traffics by a large number of routes (FiG. 5) , and excess, aberrant cholesterol deposition is the cause of atherosclerosis, the foremost cause of human death worldwide. Failed transport of cholesterol from lysosomes is also seen in inherited lipid storage disorders known as Niemann-Pick type C (NPC) disease. In addition, cholesterol traffic can be hijacked by viruses to fuel their own replication. This section exemplifies how knowledge of lipid transport mechanisms can contribute to better understanding of human pathophysiology.
Traffic from site of synthesis
Cholesterol generates membranes that are more impermeable to water by causing tighter packing of the membrane lipids, and it increases the overall thickness of a membrane by straightening acyl chains 1 . Cholesterol is synthesized mainly in the ER and is exported from there to all other membranes, including mitochondria, where it can be converted irreversibly into bile acids or steroid hormones. Export from the ER is mediated by LTPs such as StARTs, ORPs and LAMs. Possibly because of overlapping specificities, there is redundancy between these different LTPs, explaining why defects of individual proteins are not linked to specific
AAA ATPase
A protein that couples energy generated by ATP hydrolysis with conformational changes. The variable amino terminus of these proteins is usually involved in substrate recognition. ATP consumption results in energy input into the substrate so that AAA ATPases can act as pumps (see AbC transporters) or as chaperones that change their substrates' conformation. One chaperone in yeast is Afg2p, which binds Osh1.
Nuclear steroid receptors
Soluble intracellular receptors for steroid hormones (cortisol, oestrogen, etc.) that consist of a steroid-binding domain and a DNA-binding domain. in response to ligand binding, they translocate to the nucleus and regulate transcription.
γδ T cells
T cell subpopulation mostly found in the gut mucosa that expresses a T cell receptor made of one γ and one δ chain (as opposed to the majority of T cells, which express αβ chains). They have a major role in recognizing lipid antigens.
diseases. Nevertheless, the inhibition of these LTPs might be therapeutically beneficial to combat viral infection, as this pathway is hijacked by plus-strand RNA viruses. Replication of plus-strand RNA viruses requires the establishment and expansion of a specialized replication organelle, which is mostly formed from the lipids of the host's secretory pathway, either the Golgi apparatus 120 or the ER in the case of hepatitis C virus 100 . Replication organelles are double-membrane structures that contain high concentrations of cholesterol, which is delivered by ORPs in a counter-current with PtdIns(4)P. Most viruses hijack cellular PI4Ks to their replication organ elles, which then powers delivery of cholesterol across contact sites between the replication organelle and a cholesterol source, typically the ER, but for hepatitis C virus chol esterol can be delivered also from endosomes. This explains the role of molecules that block the internal cavity of ORPs as inhibitors of viral replication 121 . Viral replication is further supported by STARD3 and Niemann-Pick C1 protein (NPC1), which mediate intracellular cholesterol traffic from endosomes to replication organelles (see below) 100 . . Export of unesterified cholesterol also takes place from the plasma membrane to ApoA1, powered by the phospholipid pump ABCA1 and to pre-formed HDL nanodiscs powered by ABCG1, as described above 89 . Mutations in ABCA1 cause Tangier disease, which is characterized by aberrant cholesterol ester deposits.
Cholesterol traffic out of cells

Traffic between lipoproteins
Once cholesterol is secreted in lipoproteins, extracellular LTPs can transfer cholesterol between them. CETP transfers sterol esters from HDL to LDL or VLDL. Because of much genetic evidence correlating CETP function with the development of atherosclerosis, several specific CETP inhibitors that bind in its pocket to Lipoproteins in the circulation exchange cholesterol esters via cholesteryl ester transfer protein (CETP). Most cells acquire cholesterol from circulating lipoproteins, which are endocytosed and trafficked via early endosomes to late endosomes and lysosomes (here combined as late endosome/lysosome for simplicity). In the population of endosomes that contain epidermal growth factor receptor (EGFR), if cholesterol is not delivered from lipoproteins, then StAR-related lipid transfer protein 3 (STARD3) and ORP1 traffic cholesterol from the ER to allow endosomal maturation by the formation of intraluminal vesicles (ILVs). After acidification, cholesterol esters are hydrolysed and large amounts of free cholesterol are released. Exit of cholesterol to the limiting membrane requires hydrophobic hand-off of free cholesterol between Niemann-Pick C2 protein (NPC2) and NPC1 within the late endosome/lysosome lumen. ORP1 traffics released cholesterol to the ER and STARD3 is implicated in cholesterol transport to mitochondria. Cholesterol traffic from all intracellular sources to mitochondria is very high in steroidogenic cells, where StAR , also called STARD1, imports cholesterol all the way to the mitochondrial matrix. LDL , low-density lipoprotein; NPC, Niemann-Pick type C; VLDL , very-low-density lipoprotein. prevent lipid transfer have been extensively (and expensively) tested over the past 30 years. These drugs change lipoprotein profiles substantially but have not delivered the expected improvement in clinical outcome. This example shows how biomarkers (here blood lipids) may not be valid treatment end points 52 .
Traffic inside late endosomes and lysosomes
Lipoproteins are taken up by endocytosis, finally arriving at the lysosomes by processes that do not involve LTPs. This arrival is followed by degradation and release of free cholesterol and distribution of sterol from lysosomes to other membranes, including back to the ER, steps that do require LTPs. Exit of cholesterol and other lipids from late endosomes and lysosomes is inhibited in NPC disease, a rare neurodegenerative disorder caused by mutations in either NPC1 (95% of cases) or NPC2 (5% of cases). NPC2 is an MD2-like LTP specific for cholesterol, which picks up cholesterol from intraluminal vesicle membranes and lipoproteins and delivers it to the lysosomal limiting membrane. NPC2 engages in 'hydrophobic hand-off ' with the amino-terminal domain of NPC1, delivering cholesterol directly to it 124 . NPC1 is a large multidomain protein: its amino terminus comprises a cholesterolspecific lipid transfer domain, which is exposed to the lysosomal lumen 125 and delivers cholesterol to the lysosomal bilayer for export; the rest of the protein is a channel related to bacterial resistance-nodulationdivision efflux transporters 126 . NPC1 disease can occur with mutations in either of the domains of NPC1; therefore, their function is linked, but the link is not simple because NPC1 does not function as a transmembrane transporter for cholesterol 126 .
Traffic to other compartments
Once in the limiting membrane of late endosomes and lysosomes, LDL-derived cholesterol is destined either for the plasma membrane by vesicular recycling or for the ER by non-vesicular traffic. ORP1L is strongly implicated in the latter step, and it forms ER-late endosome and/or lysosome bridges 114 . Certain cancers are linked to mishandling of cholesterol derived from late endosomes or lysosomes. One LTP associated with cancer is STARD3, the gene locus of which is in a region often amplified in breast cancer 127 . Unlike StAR and other close relatives in humans, STARD3 has transmembrane domains anchoring it in endosomal membranes. STARD3 also has a FFAT-like motif, suggesting that it can shuttle lipid between endosomes and the ER. However, its function, and its likely contribution to oncogenic signalling, is not to move sterol out of endosomal compartments; rather, STARD3 moves cholesterol into endosomes from the ER
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. This traffic towards endosomes is similar to the delivery of cholesterol by ORP1L from ER to specialized endosomes containing epidermal growth factor receptor to promote endosomal maturation by inward budding of intraluminal vesicles 129 (FiG. 5) . Overexpression of STARD3 also affects cholesterol traffic to mitochondria, increasing their cholesterol content, although it is not known whether it directly traffics lipid from late endosomes or lysosomes 130 . More work is required to show how cholesterol handling by STARD3 enhances the malignancy of breast tumours. Perhaps it is unexpected that the same LTP can move the same lipid in different directions in different contexts, but there is good evidence for ORP1L transporting cholesterol in opposite directions 114, 129 . High-rate cholesterol trafficking to mitochondria is a specialized function of adrenal cortex cells, which convert cholesterol into pregnenolone inside mitochondria in the first step of the synthesis of glucocorticoids, mineralocorticoids and sex hormones. It was long known that loss of enzymes in these pathways causes various combinations of congenital adrenal hyperplasia and sexual development disorders. A similar syndrome is caused by mutations in STAR, which does not encode an enzyme. Composed of an amino-terminal mitochondrial localization sequence and a cholesterol-specific StARkin domain, StAR is required for pregnenolone synthesis in mitochondria 131 . Its mechanism of action is not fully understood, but it seems to act in two phases: first on the outer mitochondrial membrane StAR recruits sterol from the ER; the protein is also proteolytically cleaved and imported into the mitochondrial intermembrane space and matrix, where it acts to further stimulate production of steroids 132 .
Conclusions and perspective
The field of lipid traffic is advancing on many fronts. Working out where lipid traffic takes place has been a major factor behind the revolution in cell biology that has revealed the functional importance of non-vesicular communication between organelles. In the future, possibly further organelle pairs will be added to the list of those bridged by LTPs. Another development in lipid traffic has been the counter-current model, which links traffic of common membrane lipids (phospholipids and cholesterol) with much rarer phosphoinositides. It remains to be shown how widespread that pathway is and how much of the cell's total energy it consumes. Most recently, the use of ultrastructural analysis by electron microscopy has allowed identification of multimeric LTPs and provided evidence that a structural element as simple as an α-helix can transfer lipid so long as it multimerizes to form a hydrophobic channel wide enough for lipids to fit inside. Extending this work may identify many more protein modules that can act as bridges and tubes, including in eukaryotes. As this Review went to press, the exciting news came out that putative LTP bridges in eukaryotes have been found 133 ; next, this major development must be integrated into the changing picture of lipid traffic. In the future, it will be particularly important to understand and bring together the very different timescales that are relevant for non-vesicular lipid transfer: the millisecond range, during which LTPs load and unload the lipid; the seconds to minute range, during which lipids move between compartments; and up to the lifetime range related to physiological functions of LTPs and their contribution to health and disease. 
Tangier disease
Congenital lack of high-desnity lipoprotein (HDl) through mutation of both genes coding for AbCA1 so that HDl is not formed. Cholesterol builds up as cholesterol ester deposits in otherwise unusual sites, including tonsils, peripheral nerves and the intestine in addition to causing accelerated atherosclerosis.
Intraluminal vesicle
A vesicle generated during endosome maturation by inward budding of the endosomal limiting membrane. When secretory lysosomes fuse with the plasma membrane, intraluminal vesicles are secreted as exosomes.
Resistance-nodulationdivision efflux transporters
This large family of permeases (sometimes called pumps, but almost all devoid of ATPase activity) form selective channels for a very wide range of compounds in all kingdoms of life.
